---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-098817"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T04:57:02.392250+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq notice on April 24, 2025 confirming compliance with Listing Rule 5550(a)(2).
- Rule requires minimum bid price of $1.00 per share for continued listing.
- Company had previously been notified of deficiency; now resolved.
- No other regulatory or operational updates provided.

## SEC filing metadata
- accession: 0001193125-25-098817
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312525098817/0001193125-25-098817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312525098817/d935409d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-098817
- JSON: https://secwatch.observer/filing/0001193125-25-098817.json
- Plain text: https://secwatch.observer/filing/0001193125-25-098817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.